Chelsea Amo Tweneboah, MD(@catweneboah) 's Twitter Profileg
Chelsea Amo Tweneboah, MD

@catweneboah

PGY-1 Internal Medicine Resident @StonyBrookMed |🫀 @Cardionerds Academy Intern | @AMWAStudent GH Fellow | @GlassHealthHQ Contributor

ID:1519677447184297989

linkhttps://www.amazon.com/hz/wishlist/ls/1XXVOE7W5EXWD?ref_=wl_share calendar_today28-04-2022 13:59:09

1,1K Tweets

746 Followers

675 Following

Glass Health(@GlassHealthHQ) 's Twitter Profile Photo

Glass Health is thrilled to be 1 of 15 startups in the USA selected for the Google for Startups Accelerator: AI First Program!

blog.glass.health/glass-health-j…

Google Cloud Google Cloud Partners

account_circle
Glass Health(@GlassHealthHQ) 's Twitter Profile Photo

Read about the inaugural cohort of fifteen pioneering AI startups, including glass.health, who have joined the Google for Startups Accelerator: AI First North America.✨

developers.googleblog.com/2024/04/meet-g…

account_circle
Richard Ferraro(@RichardAFerraro) 's Twitter Profile Photo

My quick, ⬆️or ⬇️, top 3 takeaways from with explainations in thread below:

1) Polypharmacy is ⬇️!

What a conference for trimming the meds. B-blockers post-MI took a hit in REDUCE-AMI, while shorter DAPT duration got ⬆️ support from the Ultimate DAPT trial. What's next?

My quick, ⬆️or ⬇️, top 3 takeaways from #ACC24 with explainations in thread below: 1) Polypharmacy is ⬇️! What a conference for trimming the meds. B-blockers post-MI took a hit in REDUCE-AMI, while shorter DAPT duration got ⬆️ support from the Ultimate DAPT trial. What's next?
account_circle
Saad Ur Rahman(@SaadUrRahman55) 's Twitter Profile Photo

Takeaways from . Late breaking trials - take home points American College of Cardiology

1. RELIEVE-HF Trial: In patients with HFrEF and HFpEF, Interatrial Shunt did not show any significant difference in the primary effectiveness endpoint, a composite of all-cause mortality, LVAD/heart…

account_circle
Quinn Capers, IV(@DrQuinnCapers4) 's Twitter Profile Photo


Behold 400 aspiring cardiologists that identify as either Black, Hispanic, Native American, women, or LGBTQ: the most underrepresented groups in cardiology. Eliminating 🫀 disparities will require a diverse group of cardiologists.
American College of Cardiology Association of Black Cardiologists AHA Science

#ACC24 Behold 400 aspiring cardiologists that identify as either Black, Hispanic, Native American, women, or LGBTQ: the most underrepresented groups in cardiology. Eliminating 🫀 disparities will require a diverse group of cardiologists. @ACCinTouch @ABCardio1 @AHAScience
account_circle
Clarence Tsai, MD(@clarencetsaiMD) 's Twitter Profile Photo

If you are at come say hi! 👋 to our Glass Health team Maxwell Coll, MD Emily Tat Nicholas Kassis Chelsea Amo Tweneboah, MD

We would love to connect and demonstrate how you can use AI to bring more equitable and evidence-based care to your patients! ❤️

account_circle
Nazli Okumus(@nazliokumus) 's Twitter Profile Photo

Excited to share findings from the trial from Jacob Moller CardioNerds
🫀international, multicenter, randomized trial
🫀patients with STEMI and cardiogenic shock were assigned to Impella CP vs standard care only

Excited to share findings from the #DanGer trial #ACC24 from Jacob Moller @CardioNerds #cardiogenicshock #ImpellaCS 🫀international, multicenter, randomized trial 🫀patients with STEMI and cardiogenic shock were assigned to Impella CP vs standard care only #NEJM
account_circle
Nazli Okumus(@nazliokumus) 's Twitter Profile Photo

Trial the largest trial comparing the hemodynamic performance and clinical outcomes of SEV to BEV with more than 85% female representation
🫀SEV was superior to BEV for bioprosthetic valve dysfunction at 12 months for all definitions tested CardioNerds

#SMART Trial #ACC24 the largest trial comparing the hemodynamic performance and clinical outcomes of SEV to BEV with more than 85% female representation 🫀SEV was superior to BEV for bioprosthetic valve dysfunction at 12 months for all definitions tested @CardioNerds #TAVR
account_circle
Amit Goyal MD MAS(@AmitGoyalMD) 's Twitter Profile Photo

Incredible to see the impact of the CardioNerds Clinical Trial Network on the ZEUS trial in pairing equitable recruitment with professional development. So proud of this extraordinary group!

Incredible to see the impact of the @CardioNerds Clinical Trial Network on the ZEUS trial in pairing equitable recruitment with professional development. So proud of this extraordinary group! #ACC24
account_circle
Glass Health(@GlassHealthHQ) 's Twitter Profile Photo

🦠 Infective Endocarditis (IE)- A Heart-felt Overview 💥

Take your understanding of endocarditis to the next level with a high-yield Glass Health 🧵👇

1/18

🦠 Infective Endocarditis (IE)- A Heart-felt Overview 💥 Take your understanding of endocarditis to the next level with a high-yield @GlassHealthHQ 🧵👇 1/18
account_circle
Diane Masket, MS(@DianeMasket) 's Twitter Profile Photo

🔥 hot off the press 🔥

Listen to the the latest CardioNerds GLP-1 agonists episode! 🤓

Ep: 363 GLP-1 Agonists: Diving into the Data with Dr. Darren McGuire

Led by Richard Ferraro, Ty Sweeney, MD and Dr. Franck Azobou 🙌

cardionerds.com/363-glp-1-agon…

🔥 hot off the press 🔥 Listen to the the latest @CardioNerds GLP-1 agonists episode! 🤓 Ep: 363 GLP-1 Agonists: Diving into the Data with Dr. Darren McGuire Led by @RichardAFerraro, @TySweeney6 and Dr. Franck Azobou 🙌 cardionerds.com/363-glp-1-agon…
account_circle
Patrick Zakka, MD(@PatrickZakka) 's Twitter Profile Photo

Let's talk about risk scores in cardiogenic shock! Dr. Lansky Alexandra Lansky presents a fantastic talk at on available risk scores and their utility in cardiogenic shock. HoustonShock CardioNerds

Let's talk about risk scores in cardiogenic shock! Dr. Lansky @AlexandraLansky presents a fantastic talk at #HSS24 on available risk scores and their utility in cardiogenic shock. @HoustonShockHSS @CardioNerds
account_circle
Maryam Barkhordarian(@MaryamBMD) 's Twitter Profile Photo

How often do you ask your patients about PAD symptoms?
If you want to learn more, check out this CardioNerds infographic about 'Peripheral arterial disease'!

Especial thanks to Victoria Thomas Rawan Amir Amit Goyal MD MAS for reviewing.

How often do you ask your patients about PAD symptoms? If you want to learn more, check out this @CardioNerds infographic about 'Peripheral arterial disease'! Especial thanks to @Drvic_thomas @RawanAAmir @AmitGoyalMD for reviewing.
account_circle